M. Donker

发表

Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

E. Rutgers, J. Wesseling, M. Schot, 2015, Annals of surgery.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

R. Mansel, E. Rutgers, J. Bogaerts, 2014, The Lancet. Oncology.

Radiation-Enhanced Vascular Endothelial Growth Factor (VEGF) Secretion in Glioblastoma Multiforme Cell Lines – A Clue to Radioresistance?

L. Stalpers, J. Verhoeff, D. Bosch, 2005, Journal of Neuro-Oncology.

Negligible radiation protection of endothelial cells by vascular endothelial growth factor.

L. Stalpers, J. Verhoeff, M. Donker, 2007, Oncology reports.

Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma

K. Shokat, Z. Knight, D. Stokoe, 2008, Molecular Cancer Therapeutics.

Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy

E. Rutgers, M. Straver, M. V. Vrancken Peeters, 2017, The British journal of surgery.

Reply to Letter: "Response to Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?".

E. Rutgers, M. Donker, M. V. Vrancken Peeters, 2016, Annals of surgery.

Radiotherapy or surgery for the axilla in node-positive breast cancer?--authors' reply.

E. Rutgers, L. Slaets, M. Donker, 2015, The Lancet. Oncology.

Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome.

R. Mansel, E. Rutgers, S. Litière, 2013, European journal of cancer.

Abstract GS4-01: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023)

R. Mansel, J. Bogaerts, G. Tienhoven, 2019, General Session Abstracts.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

H. Bartelink, I. Fentiman, S. Litière, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Angiogenesis inhibition in high grade glioma Verhoeff

W. Vandertop, D. Troost, L. Stalpers, 2009 .

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

W. Vandertop, D. Troost, L. Stalpers, 2009, Cancer letters.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023).

R. Mansel, J. Bogaerts, C. V. D. van de Velde, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Guiding Breast-Conserving Surgery in Patients After Neoadjuvant Systemic Therapy for Breast Cancer: A Comparison of Radioactive Seed Localization with the ROLL Technique

E. Rutgers, J. Wesseling, T. Alderliesten, 2013, Annals of Surgical Oncology.

Radioguided occult lesion localisation (ROLL) in breast-conserving surgery after neoadjuvant chemotherapy.

E. Rutgers, J. Wesseling, G. Sonke, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Is DCIS Breast Cancer, and How Do I Treat it?

J. Wesseling, E. Rutgers, M. Donker, 2013, Current Treatment Options in Oncology.

Improvements in locoregional treatment of breast cancer

M. Donker, 2014 .

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.

T. D. de Reijke, M. Hulshof, J. Oddens, 2022, European urology.

MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology.

B. Erickson, T. Kim, P. Parikh, 2020, International journal of radiation oncology, biology, physics.

Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.

E. Rutgers, G. Sonke, M. V. Vrancken Peeters, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial

E. Rutgers, R. Mansel, C. V. D. van de Velde, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Local recurrence after skin-sparing mastectomy].

M. V. Vrancken Peeters, M. Donker, O. Brouwer, 2012, Nederlands tijdschrift voor geneeskunde.

Is axillary lymph node clearance required in node-positive breast cancer?

E. Rutgers, N. Bundred, M. Donker, 2015, Nature Reviews Clinical Oncology.

Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality.

B. van Triest, L. Dewit, Joost J. M. van Griethuysen, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

J. Bogaerts, G. Tienhoven, G. Nieuwenhuijzen, 2014, The Lancet. Oncology.

[Axillary lymph node dissection versus axillary radiotherapy in patients with a positive sentinel node: the AMAROS trial].

E. Rutgers, L. Slaets, M. Donker, 2015, Nederlands tijdschrift voor geneeskunde.